Abstract: This disclosure provides implantable devices with remote physiological monitoring capabilities. In particular, this disclosure relates to implantable devices with multi-spectral sensors that sense analyte from within a subject to provide clinically actionable data related to the subject's heath. For example, in preferred embodiments, the devices relate to ports with one or more multi-spectral sensors capable of remotely measuring symptoms of physiological distress via the multi-spectral sensors. In some embodiments, the ports are useful to deliver chemotherapy treatments and monitor patient health over the course of chemotherapy treatments. The multi-spectral sensors sense physical light properties modulated (e.g., reflected, absorbed, dispersed, scattered, etc.) by one or more analytes present in the body to allow for earlier detection of signs indicative of a health status.

Abstract: An apparatus for an implantable venous access port with remote physiological monitoring capabilities is disclosed. A system and method also perform the functions of the apparatus. In one embodiment the apparatus includes a chemotherapy access port, a plurality of sensors integrated with the chemotherapy access port, where the plurality of sensors determine one or more chemotherapy-related physiological indicators and the one or more physiological indicators include at least parameters selected from red blood cell count, white blood cell count, platelets, and/or ejection fraction. The apparatus includes a communications module integrated with the chemotherapy access port, where the communications module is configured to communicate the one or more chemotherapy-related physiological indicators to a computing device.

Abstract: An apparatus for an implantable venous access port with remote physiological monitoring capabilities is disclosed. A system and method also perform the functions of the apparatus. In one embodiment the apparatus includes a chemotherapy access port, a plurality of sensors integrated with the chemotherapy access port, where the plurality of sensors determine one or more chemotherapy-related physiological indicators and the one or more physiological indicators include at least parameters selected from red blood cell count, white blood cell count, platelets, and/or ejection fraction. The apparatus includes a communications module integrated with the chemotherapy access port, where the communications module is configured to communicate the one or more chemotherapy-related physiological indicators to a computing device.